Vaccinex, Inc.
VCNX · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,057 | $4,284 | $27,160 | $29,840 |
| - Cash | $1,107 | $1,535 | $6,391 | $8,589 |
| + Debt | $25 | $247 | $485 | $390 |
| Enterprise Value | $975 | $2,996 | $21,254 | $21,641 |
| Revenue | $601 | $570 | $100 | $900 |
| % Growth | 5.4% | 470% | -88.9% | – |
| Gross Profit | $601 | $570 | $68 | $731 |
| % Margin | 100% | 100% | 68% | 81.2% |
| EBITDA | -$18,538 | -$19,748 | -$19,606 | -$21,402 |
| % Margin | -3,084.5% | -3,464.6% | -19,606% | -2,378% |
| Net Income | -$18,634 | -$20,251 | -$19,722 | -$22,380 |
| % Margin | -3,100.5% | -3,552.8% | -19,722% | -2,486.7% |
| EPS Diluted | -8.88 | -43.68 | -97.59 | -162.91 |
| % Growth | 79.7% | 55.2% | 40.1% | – |
| Operating Cash Flow | -$16,186 | -$17,234 | -$19,074 | -$25,298 |
| Capital Expenditures | -$22 | -$67 | -$99 | -$32 |
| Free Cash Flow | -$16,208 | -$17,301 | -$19,173 | -$25,330 |